Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Montpellier
Age
35–85
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
35 to 85 years old
COPD patients: association of symtoms (breathlessness, cough, sputum) and chronic exposure to inhalated risk factors (like tobacco smoke) and a FEV1/VC ratio \<70% assessed by a spirometry
Healthy subjects: A sedentariness assessed by a Voorrips score \<9.4 and/or a report of \<150 min/week of moderate-to-vigorous physical activity
You may not be if
A recent COPD exacerbation (\< 4weeks)
The decompensation of a comorbidity
An antioxidant supplementation or medication
A long-term systemic corticosteroid medication
Clareo Health | Involvement of Plasmatic Factors in the Peripheral Muscle Dysfunction of COPD Patients - In Vitro Study
